Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
On Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug Administration (FDA), the regulatory body in the United States. These observations pertain to its biologics manufacturing facility located in Bachupally, Hyderabad.
On Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug Administration (FDA), the regulatory body in the United States. These observations pertain to its biologics manufacturing facility located in Bachupally, Hyderabad.
We use cookies to improve your experience on our site and to show you relevant advertising. To find out more, read our updated privacy policy and cookie policy
Through RSS Feeds 
On Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug Administration (FDA), the regulatory body in the United States. These observations pertain to its biologics manufacturing facility located in Bachupally, Hyderabad. 
